130121540_GAURAV_AGRAWAL_16Nov2013_214918_WL

Embed Size (px)

Citation preview

  • 8/13/2019 130121540_GAURAV_AGRAWAL_16Nov2013_214918_WL

    1/4

    GAURAV AGRAWAL Reference:Dr.MEENA DESAIReference:Dr.MEENA DESAI

    HINGOLI SID: 130121540

    Collected On:

    16/11/2013 00:00

    Tel No: 9421865261 Registered On:

    16/11/2013 10:28 AM

    PID NO: 44058 Reported On:

    Age:9.05 Years Sex:CHILD 16/11/2013 08:35 PM

    Test Description Observed Value Biological Reference IntervalTest Description Observed Value Biological Reference IntervalTest Description Observed Value Biological Reference IntervalTest Description Observed Value Biological Reference Interval

    Biochemistry :

    Sodium, serum by ISE method 141 Premature, cord : 116 to 140 mmol/LPremature 48 hrs : 128 to 148 mmol/LNewborn cord : 126 to 166 mmol/LNewborn : 133 to 146 mmol/LInfant : 139 to 146 mmol/LChild : 138 to 145 mmol/L

    Potassium, serum by ISE method 4.1 Premature cord : 5 to 10.2 mmol/L

    Premature , 48 hrs : 3.0 to 6.0 mmol/L

    Newborn cord : 5.6 to 12 mmol/LNewborn : 3.7 to 5.9 mmol/L

    Infant : 4.1 to 5.3 mmol/L

    Child : 3.4 to 4.7 mmol/L

    Chlorides, serum by ISE method 106.0 Cord : 96 to 104 mmol/L

    New born :

    0 to 30 days : 98 to 113 mmol/L

    1 Month to 12 yrs : 98 to 107 mmol/L

    Calcium serum by Arsenazo III dye method 9.60 0-12 months : 9.2-11.2 mg/dL

    1-5 yrs : 9.2-10.4 mg/dL

    6-10 yrs : 9.2-10.4 mg/dL

    11-14 yrs : 8.8-10.4 mg/dL

    15-20 yrs : 8.8-10.4 mg/dLRef: Pediatric Reference Intervals,

    7 th Edition.AACC Press 2011.

    Page 1 of 4

  • 8/13/2019 130121540_GAURAV_AGRAWAL_16Nov2013_214918_WL

    2/4

    GAURAV AGRAWAL Reference:Dr.MEENA DESAIReference:Dr.MEENA DESAI

    HINGOLI SID: 130121540

    Collected On:

    16/11/2013 00:00

    Tel No: 9421865261 Registered On:

    16/11/2013 10:28 AM

    PID NO: 44058 Reported On:

    Age:9.05 Years Sex:CHILD 16/11/2013 08:35 PM

    Test Description Observed Value Biological Reference IntervalTest Description Observed Value Biological Reference IntervalTest Description Observed Value Biological Reference IntervalTest Description Observed Value Biological Reference Interval

    Biochemistry :

    Phosphorous,serum by Phospomolybdatemethod

    5.50 Male

    0-12 months : 4.8-7.8 mg/dL

    1-5 yrs : 4.4-6.8 mg/dL

    6-10 yrs : 3.8-6.2 mg/dL

    11-14 yrs : 3.8-6.1 mg/dL

    15-20 yrs : 2.7-5.4 mg/dL

    Female

    0-12 months : 4.8-7.8 mg/dL

    1-5 yrs : 4.4-6.8 mg/dL

    6-10 yrs : 3.8-6.2 mg/dL11-14 yrs : 3.0- 5.8 mg/dL

    15-20 yrs : 3.3-5.0 mg/dL

    Ref: Pediatric Reference Intervals,

    7 th Edition.AACC Press 2011.

    Biochemistry- Enzymes

    Alkaline Phosphatase,serum by pNPP method 221 Male

    0-12 months : 150-507 U/L

    1-5 yrs : 152-767 U/L

    6-10 yrs : 135-537 U/L11-14 ys : 92-549 U/L

    15-20 yrs : 62-369 U/L

    Female

    0-12 months : 150-507 U/L

    1-5 yrs : 152-767 U/L

    6-10 yrs : 135-537 U/L

    11-14 ys : 50-415 U/L

    15-20 yrs : 47-175 U/L

    Ref: Pediatric Reference Intervals,

    7 th Edition.AACC Press 2011.

    Page 2 of 4

  • 8/13/2019 130121540_GAURAV_AGRAWAL_16Nov2013_214918_WL

    3/4

    GAURAV AGRAWAL Reference:Dr.MEENA DESAIReference:Dr.MEENA DESAI

    HINGOLI SID: 130121540

    Collected On:

    16/11/2013 00:00

    Tel No: 9421865261 Registered On:

    16/11/2013 10:28 AM

    PID NO: 44058 Reported On:

    Age:9.05 Years Sex:CHILD 16/11/2013 08:35 PM

    Test Description Observed Value Biological Reference IntervalTest Description Observed Value Biological Reference IntervalTest Description Observed Value Biological Reference IntervalTest Description Observed Value Biological Reference Interval

    Hormones :

    DHEAS, serum by CLIA BELOW 15 Age Boy Girl (g/dL)l

    RECHECKED 8 -15days : 37 - 224 44 -2478-15 days : 37 -224 44-2471-3 yrs : 6-21 6-794-6 yrs : 5-186 6-387-8 yrs : 10-94 13-689-10 yrs : 16-75 14-16011 yrs : 20-152 12-9812 yrs : 18-344 28-17713 yrs : 21-243 23-16714 yrs : 19-286 32-30115 yrs : 59-310 39-28816 yrs : 47-357 58-35417 yrs : 102-341 97-39918-19 yrs : 108-441 145-395(Reference as per kit insert)1 month-1 yr : 1-41 5-55Reference :TIETZ Fundamentals of Clinical Chemistry)

    Page 3 of 4

  • 8/13/2019 130121540_GAURAV_AGRAWAL_16Nov2013_214918_WL

    4/4

    GAURAV AGRAWAL Reference:Dr.MEENA DESAIReference:Dr.MEENA DESAI

    HINGOLI SID: 130121540

    Collected On:

    16/11/2013 00:00

    Tel No: 9421865261 Registered On:

    16/11/2013 10:28 AM

    PID NO: 44058 Reported On:

    Age:9.05 Years Sex:CHILD 16/11/2013 08:35 PM

    Test Description Observed Value Biological Reference IntervalTest Description Observed Value Biological Reference IntervalTest Description Observed Value Biological Reference IntervalTest Description Observed Value Biological Reference Interval

    Vitamins :

    25 Hydroxy (OH) Vit D,serum by CLIA 13.50 Deficiency : Below 10 ng/ml

    Insufficiency : 10 to 30 ng/ml

    Sufficiency : 30 to 100 ng/ml

    Toxicity : Above 100 ng/ml

    Vitamin D is a fat soluble vitamin and exists in two main forms as cholecalciferol(vitamin D3) which is synthesized inskin from 7-dehydrocholesterol in response to sunlight exposure & Ergocalciferol(vitamin D2) present mainly indietary sources.Both cholecalciferol & Ergocalciferol are converted to 25(OH)vitamin D in liver.Testing for 25(OH)vitamin D is recommended as it is the best indicator of vitamin D nutritional status as obtainedfrom sunlight exposure & dietary intake. For diagnosis of vitamin D deficiency it is recommended to

    have clinical correlation with serum 25(OH)vitamin D, serum calcium, serum PTH & serum alkaline phosphatase.During monitoring of oral vitamin D therapy- suggested testing of serum 25(OH)vitamin D is after 12 weeks or 3 mthsof treatment. However, the required dosage of vitamin D supplements & time to achieve sufficient vitamin Dlevels show significant seasonal(especially winter) & individual variability depending on age, body fat, sunexposure, physical activity ,genetic factors(especially variable vitamin D receptor responses), associated liveror renal disease, malabsorption syndromes and calcium or magnesium deficiency influencing the vitamin Dmetabolism Vitamin D toxicity is known but very rare.kindly correlate clinically, repeat with fresh sample if indicated.. .Associated Test Profile : As a holistic & scientific approach for diagnosis andoptimal treatment for vitamin D deficiency, Vitamin D plus profile is suggested.

    Vitamin D is a fat soluble vitamin and exists in two main forms as cholecalciferol(vitamin D3) which is synthesized inskin from 7-dehydrocholesterol in response to sunlight exposure & Ergocalciferol(vitamin D2) present mainly indietary sources.Both cholecalciferol & Ergocalciferol are converted to 25(OH)vitamin D in liver.Testing for 25(OH)vitamin D is recommended as it is the best indicator of vitamin D nutritional status as obtainedfrom sunlight exposure & dietary intake. For diagnosis of vitamin D deficiency it is recommended to

    have clinical correlation with serum 25(OH)vitamin D, serum calcium, serum PTH & serum alkaline phosphatase.During monitoring of oral vitamin D therapy- suggested testing of serum 25(OH)vitamin D is after 12 weeks or 3 mthsof treatment. However, the required dosage of vitamin D supplements & time to achieve sufficient vitamin Dlevels show significant seasonal(especially winter) & individual variability depending on age, body fat, sunexposure, physical activity ,genetic factors(especially variable vitamin D receptor responses), associated liveror renal disease, malabsorption syndromes and calcium or magnesium deficiency influencing the vitamin Dmetabolism Vitamin D toxicity is known but very rare.kindly correlate clinically, repeat with fresh sample if indicated.. .Associated Test Profile : As a holistic & scientific approach for diagnosis andoptimal treatment for vitamin D deficiency, Vitamin D plus profile is suggested.

    Vitamin D is a fat soluble vitamin and exists in two main forms as cholecalciferol(vitamin D3) which is synthesized inskin from 7-dehydrocholesterol in response to sunlight exposure & Ergocalciferol(vitamin D2) present mainly indietary sources.Both cholecalciferol & Ergocalciferol are converted to 25(OH)vitamin D in liver.Testing for 25(OH)vitamin D is recommended as it is the best indicator of vitamin D nutritional status as obtainedfrom sunlight exposure & dietary intake. For diagnosis of vitamin D deficiency it is recommended to

    have clinical correlation with serum 25(OH)vitamin D, serum calcium, serum PTH & serum alkaline phosphatase.During monitoring of oral vitamin D therapy- suggested testing of serum 25(OH)vitamin D is after 12 weeks or 3 mthsof treatment. However, the required dosage of vitamin D supplements & time to achieve sufficient vitamin Dlevels show significant seasonal(especially winter) & individual variability depending on age, body fat, sunexposure, physical activity ,genetic factors(especially variable vitamin D receptor responses), associated liveror renal disease, malabsorption syndromes and calcium or magnesium deficiency influencing the vitamin Dmetabolism Vitamin D toxicity is known but very rare.kindly correlate clinically, repeat with fresh sample if indicated.. .Associated Test Profile : As a holistic & scientific approach for diagnosis andoptimal treatment for vitamin D deficiency, Vitamin D plus profile is suggested.

    Vitamin D is a fat soluble vitamin and exists in two main forms as cholecalciferol(vitamin D3) which is synthesized inskin from 7-dehydrocholesterol in response to sunlight exposure & Ergocalciferol(vitamin D2) present mainly indietary sources.Both cholecalciferol & Ergocalciferol are converted to 25(OH)vitamin D in liver.Testing for 25(OH)vitamin D is recommended as it is the best indicator of vitamin D nutritional status as obtainedfrom sunlight exposure & dietary intake. For diagnosis of vitamin D deficiency it is recommended to

    have clinical correlation with serum 25(OH)vitamin D, serum calcium, serum PTH & serum alkaline phosphatase.During monitoring of oral vitamin D therapy- suggested testing of serum 25(OH)vitamin D is after 12 weeks or 3 mthsof treatment. However, the required dosage of vitamin D supplements & time to achieve sufficient vitamin Dlevels show significant seasonal(especially winter) & individual variability depending on age, body fat, sunexposure, physical activity ,genetic factors(especially variable vitamin D receptor responses), associated liveror renal disease, malabsorption syndromes and calcium or magnesium deficiency influencing the vitamin Dmetabolism Vitamin D toxicity is known but very rare.kindly correlate clinically, repeat with fresh sample if indicated.. .Associated Test Profile : As a holistic & scientific approach for diagnosis andoptimal treatment for vitamin D deficiency, Vitamin D plus profile is suggested.

    End of ReportEnd of ReportEnd of ReportEnd of Report

    Page 4 of 4